{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:57:45Z","timestamp":1787003865803,"version":"build-2736575974"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P50CA228991"],"award-info":[{"award-number":["P50CA228991"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P50CA217685"],"award-info":[{"award-number":["P50CA217685"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["F32CA221093"],"award-info":[{"award-number":["F32CA221093"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"DOI":"10.13039\/100005984","name":"Dr. Miriam and Sheldon G. Adelson Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005984","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006800","name":"Honorable Tina Brozman Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006800","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001036","name":"Claneil Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001036","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013401","name":"Ovarian Cancer Research Fund Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013401","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foundation for the Improvement of Research in Gynecology and Obstetrics in Lausanne University Hospital. Stanley Parker Foundation."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Most ovarian high-grade serous carcinomas (HGSC) arise from Serous Tubal Intraepithelial Carcinoma (STIC) lesions in the distal end of the fallopian tube (FT). Formation of STIC lesions from FT secretory cells leads to seeding of the ovarian surface, with rapid tumor dissemination to other abdominal structures thereafter. It remains unclear how nascent malignant cells leave the FT to colonize the ovary. This report provides evidence that the L1 cell adhesion molecule (L1CAM) contributes to the ability of transformed FT secretory cells (FTSEC) to detach from the tube, survive under anchorage-independent conditions, and seed the ovarian surface. L1CAM was highly expressed on the apical cells of STIC lesions and contributed to ovarian colonization by upregulating integrins and fibronectin in malignant cells and activating the AKT and ERK pathways. These changes increased cell survival under ultra-low attachment conditions that mimic transit from the FT to the ovary. To study dissemination to the ovary, we developed a tumor-ovary co-culture model. We showed that L1CAM expression was important for FT cells to invade the ovary as a cohesive group. Our results indicate that in the early stages of HGSC development, transformed FTSECs disseminate from the FT to the ovary in a L1CAM-dependent manner.<\/jats:p>","DOI":"10.1038\/s42003-022-04314-8","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T06:03:15Z","timestamp":1670824995000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["L1CAM is required for early dissemination of fallopian tube carcinoma precursors to the ovary"],"prefix":"10.1038","volume":"5","author":[{"given":"Kai","family":"Doberstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Spivak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hunter D.","family":"Reavis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5001-6092","authenticated-orcid":false,"given":"Jagmohan","family":"Hooda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Paul T.","family":"Kroeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Stuckelberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0144-9614","authenticated-orcid":false,"given":"Gordon B.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle M.","family":"Devins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren E.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8375-8447","authenticated-orcid":false,"given":"Marcin P.","family":"Iwanicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Fogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Altevogt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6912-6977","authenticated-orcid":false,"given":"Ronny","family":"Drapkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,12]]},"reference":[{"key":"4314_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay, J. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J. Cancer 136, E359\u2013E386 (2015).","journal-title":"Int J. Cancer"},{"key":"4314_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/GCO.0000000000000340","volume":"29","author":"PT Kroeger Jr.","year":"2017","unstructured":"Kroeger, P. T. Jr. & Drapkin, R. Pathogenesis and heterogeneity of ovarian cancer. Curr. Opin. Obstet. Gynecol. 29, 26\u201334 (2017).","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"4314_CR3","first-page":"7","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer Statistics, 2017. CA: A cancer J. Clinicians. 67, 7\u201330 (2017).","journal-title":"CA: A cancer J. Clinicians."},{"key":"4314_CR4","unstructured":"Wild CP, W. E., Stewart BW. Vol. Available from: http:\/\/publications.iarc.fr\/586. (ed International Agency for Research on Cancer) (2020)."},{"key":"4314_CR5","doi-asserted-by":"publisher","first-page":"932371","DOI":"10.1155\/2010\/932371","volume":"2010","author":"AM Karst","year":"2010","unstructured":"Karst, A. M. & Drapkin, R. Ovarian cancer pathogenesis: a model in evolution. J. Oncol. 2010, 932371 (2010).","journal-title":"J. Oncol."},{"key":"4314_CR6","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nrc3144","volume":"11","author":"S Vaughan","year":"2011","unstructured":"Vaughan, S. et al. Rethinking ovarian cancer: recommendations for improving outcomes. Nat. Rev. Cancer 11, 719\u2013725, https:\/\/doi.org\/10.1038\/nrc3144 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"4314_CR7","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1158\/2159-8290.CD-16-0607","volume":"6","author":"MA Eckert","year":"2016","unstructured":"Eckert, M. A. et al. Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube. Cancer Disco. 6, 1342\u20131351 (2016).","journal-title":"Cancer Disco."},{"key":"4314_CR8","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.humpath.2011.03.003","volume":"42","author":"RJ Kurman","year":"2011","unstructured":"Kurman, R. J. & Shih Ie, M. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer\u2013shifting the paradigm. Hum. Pathol. 42, 918\u2013931 (2011).","journal-title":"Hum. Pathol."},{"key":"4314_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00962-1","volume":"8","author":"SI Labidi-Galy","year":"2017","unstructured":"Labidi-Galy, S. I. et al. High grade serous ovarian carcinomas originate in the fallopian tube. Nat. Commun. 8, 1093 (2017).","journal-title":"Nat. Commun."},{"key":"4314_CR10","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1001\/jamaoncol.2015.1618","volume":"1","author":"AS McDaniel","year":"2015","unstructured":"McDaniel, A. S. et al. Next-Generation Sequencing of Tubal Intraepithelial Carcinomas. JAMA Oncol. 1, 1128\u20131132 (2015).","journal-title":"JAMA Oncol."},{"key":"4314_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ygyno.2017.04.015","volume":"146","author":"EEK Meserve","year":"2017","unstructured":"Meserve, E. E. K. et al. Frequency of \u201cincidental\u201d serous tubal intraepithelial carcinoma (STIC) in women without a history of or genetic risk factor for high-grade serous carcinoma: A six-year study. Gynecol. Oncol. 146, 69\u201373 (2017).","journal-title":"Gynecol. Oncol."},{"key":"4314_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/PGP.0b013e3181f29d2a","volume":"30","author":"JD Seidman","year":"2011","unstructured":"Seidman, J. D., Yemelyanova, A., Zaino, R. J. & Kurman, R. J. The fallopian tube-peritoneal junction: a potential site of carcinogenesis. Int J. Gynecol. Pathol. 30, 4\u201311 (2011).","journal-title":"Int J. Gynecol. Pathol."},{"key":"4314_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/path.5219","volume":"248","author":"RC Wu","year":"2019","unstructured":"Wu, R. C. et al. Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions. J. Pathol. 248, 41\u201350 (2019).","journal-title":"J. Pathol."},{"key":"4314_CR14","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/path.2091","volume":"211","author":"Y Lee","year":"2007","unstructured":"Lee, Y. et al. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J. Pathol. 211, 26\u201335 (2007).","journal-title":"J. Pathol."},{"key":"4314_CR15","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/modpathol.2010.171","volume":"24","author":"KK Mehra","year":"2011","unstructured":"Mehra, K. K. et al. The impact of tissue block sampling on the detection of p53 signatures in fallopian tubes from women with BRCA 1 or 2 mutations (BRCA+) and controls. Mod. Pathol. 24, 152\u2013156 (2011).","journal-title":"Mod. Pathol."},{"key":"4314_CR16","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1002\/ijc.29658","volume":"138","author":"P Altevogt","year":"2016","unstructured":"Altevogt, P., Doberstein, K. & Fogel, M. L1CAM in human cancer. Int J. Cancer 138, 1565\u20131576 (2016).","journal-title":"Int J. Cancer"},{"key":"4314_CR17","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1093\/annonc\/mdr568","volume":"23","author":"S Bondong","year":"2012","unstructured":"Bondong, S. et al. Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-kappaB activation. Ann. Oncol. 23, 1795\u20131802 (2012).","journal-title":"Ann. Oncol."},{"key":"4314_CR18","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.ccell.2017.05.007","volume":"31","author":"P Agrawal","year":"2017","unstructured":"Agrawal, P. et al. A Systems Biology Approach Identifies FUT8 as a Driver of Melanoma Metastasis. Cancer Cell 31, 804\u2013819 e807 (2017).","journal-title":"Cancer Cell"},{"key":"4314_CR19","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/s41556-018-0138-8","volume":"20","author":"EE Er","year":"2018","unstructured":"Er, E. E. et al. Pericyte-like spreading by disseminated cancer cells activates YAP and MRTF for metastatic colonization. Nat. Cell Biol. 20, 966\u2013978 (2018).","journal-title":"Nat. Cell Biol."},{"key":"4314_CR20","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/onc.2016.329","volume":"36","author":"G Haase","year":"2017","unstructured":"Haase, G., Gavert, N., Brabletz, T. & Ben-Ze\u2019ev, A. A point mutation in the extracellular domain of L1 blocks its capacity to confer metastasis in colon cancer cells via CD10. Oncogene 36, 1597\u20131606 (2017).","journal-title":"Oncogene"},{"key":"4314_CR21","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/s41416-019-0646-8","volume":"121","author":"T Ichikawa","year":"2019","unstructured":"Ichikawa, T. et al. Clinical significance and biological role of L1 cell adhesion molecule in gastric cancer. Br. J. Cancer 121, 1058\u20131068 (2019).","journal-title":"Br. J. Cancer"},{"key":"4314_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01084-w","volume":"7","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. C1QBP suppresses cell adhesion and metastasis of renal carcinoma cells. Sci. Rep. 7, 999 (2017).","journal-title":"Sci. Rep."},{"key":"4314_CR23","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"N Cancer Genome Atlas Research","year":"2013","unstructured":"Cancer Genome Atlas Research, N. et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat. Genet. 45, 1113\u20131120 (2013).","journal-title":"Nat. Genet."},{"key":"4314_CR24","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"Cancer Genome Atlas Research, N.","year":"2011","unstructured":"Cancer Genome Atlas Research, N. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609\u2013615 (2011).","journal-title":"Nature"},{"key":"4314_CR25","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1158\/0008-5472.CAN-18-2297","volume":"79","author":"J Hooda","year":"2019","unstructured":"Hooda, J. et al. Early Loss of Histone H2B Monoubiquitylation Alters Chromatin Accessibility and Activates Key Immune Pathways That Facilitate Progression of Ovarian Cancer. Cancer Res. 79, 760\u2013772 (2019).","journal-title":"Cancer Res."},{"key":"4314_CR26","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.bbagrm.2014.01.002","volume":"1839","author":"G Fuchs","year":"2014","unstructured":"Fuchs, G. & Oren, M. Writing and reading H2B monoubiquitylation. Biochim Biophys. Acta. 1839, 694\u2013701 (2014).","journal-title":"Biochim Biophys. Acta."},{"key":"4314_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ygyno.2011.05.021","volume":"123","author":"AM Karst","year":"2011","unstructured":"Karst, A. M. et al. Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas. Gynecol. Oncol. 123, 5\u201312 (2011).","journal-title":"Gynecol. Oncol."},{"key":"4314_CR28","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ygyno.2015.07.100","volume":"139","author":"M Novak","year":"2015","unstructured":"Novak, M. et al. Stathmin 1 and p16(INK4A) are sensitive adjunct biomarkers for serous tubal intraepithelial carcinoma. Gynecol. Oncol. 139, 104\u2013111 (2015).","journal-title":"Gynecol. Oncol."},{"key":"4314_CR29","doi-asserted-by":"publisher","first-page":"E326","DOI":"10.1002\/ijc.29222","volume":"136","author":"K Doberstein","year":"2015","unstructured":"Doberstein, K. et al. Antibody therapy to human L1CAM in a transgenic mouse model blocks local tumor growth but induces EMT. Int. J. Cancer 136, E326\u2013E339 (2015).","journal-title":"Int. J. Cancer"},{"key":"4314_CR30","doi-asserted-by":"publisher","first-page":"e180","DOI":"10.5301\/jbm.5000055","volume":"29","author":"M Fogel","year":"2014","unstructured":"Fogel, M. et al. A standardized staining protocol for L1CAM on formalin-fixed, paraffin-embedded tissues using automated platforms. Int J. Biol. Markers. 29, e180\u2013e183 (2014).","journal-title":"Int J. Biol. Markers."},{"key":"4314_CR31","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1097\/PAS.0b013e318282da7f","volume":"37","author":"JG Bijron","year":"2013","unstructured":"Bijron, J. G. et al. Fallopian tube intraluminal tumor spread from noninvasive precursor lesions: a novel metastatic route in early pelvic carcinogenesis. Am. J. Surg. Pathol. 37, 1123\u20131130 (2013).","journal-title":"Am. J. Surg. Pathol."},{"key":"4314_CR32","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1158\/1078-0432.CCR-16-1237","volume":"23","author":"JF Liu","year":"2017","unstructured":"Liu, J. F. et al. Establishment of Patient-Derived Tumor Xenograft Models of Epithelial Ovarian Cancer for Preclinical Evaluation of Novel Therapeutics. Clin. Cancer Res. 23, 1263\u20131273 (2017).","journal-title":"Clin. Cancer Res."},{"key":"4314_CR33","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1038\/nprot.2012.097","volume":"7","author":"AM Karst","year":"2012","unstructured":"Karst, A. M. & Drapkin, R. Primary culture and immortalization of human fallopian tube secretory epithelial cells. Nat. Protoc. 7, 1755\u20131764 (2012).","journal-title":"Nat. Protoc."},{"key":"4314_CR34","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1158\/0008-5472.CAN-13-2247","volume":"74","author":"AM Karst","year":"2014","unstructured":"Karst, A. M. et al. Cyclin E1 Deregulation Occurs Early in Secretory Cell Transformation to Promote Formation of Fallopian Tube-Derived High-Grade Serous Ovarian Cancers. Cancer Res. 74, 1141\u20131152 (2014).","journal-title":"Cancer Res."},{"key":"4314_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/srep06116","volume":"4","author":"Y Yang-Hartwich","year":"2014","unstructured":"Yang-Hartwich, Y. et al. Ovulation and extra-ovarian origin of ovarian cancer. Sci. Rep. 4, 6116 (2014).","journal-title":"Sci. Rep."},{"key":"4314_CR36","doi-asserted-by":"publisher","first-page":"4766","DOI":"10.1038\/onc.2010.230","volume":"29","author":"H Kiefel","year":"2010","unstructured":"Kiefel, H. et al. L1CAM-integrin interaction induces constitutive NF-kappa B activation in pancreatic adenocarcinoma cells by enhancing IL-1 beta expression. Oncogene 29, 4766\u20134778, https:\/\/doi.org\/10.1038\/onc.2010.230 (2010).","journal-title":"Oncogene"},{"key":"4314_CR37","doi-asserted-by":"publisher","unstructured":"Iwanicki, M. P. et al. Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition. Jci Insight 1, https:\/\/doi.org\/10.1172\/jci.insight.86829 (2016).","DOI":"10.1172\/jci.insight.86829"},{"key":"4314_CR38","doi-asserted-by":"publisher","first-page":"4614","DOI":"10.1172\/JCI74778","volume":"124","author":"HA Kenny","year":"2014","unstructured":"Kenny, H. A. et al. Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion. J. Clin. Invest. 124, 4614\u20134628 (2014).","journal-title":"J. Clin. Invest."},{"key":"4314_CR39","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s10585-004-5768-5","volume":"21","author":"KM Burleson","year":"2004","unstructured":"Burleson, K. M., Hansen, L. K. & Skubitz, A. P. Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers. Clin. Exp. Metastasis. 21, 685\u2013697 (2004).","journal-title":"Clin. Exp. Metastasis."},{"key":"4314_CR40","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1038\/onc.2010.532","volume":"30","author":"AK Mitra","year":"2011","unstructured":"Mitra, A. K. et al. Ligand-independent activation of c-Met by fibronectin and alpha(5)beta(1)-integrin regulates ovarian cancer invasion and metastasis. Oncogene 30, 1566\u20131576 (2011).","journal-title":"Oncogene"},{"key":"4314_CR41","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.ygyno.2013.12.031","volume":"132","author":"JM Scalici","year":"2014","unstructured":"Scalici, J. M. et al. Inhibition of alpha4beta1 integrin increases ovarian cancer response to carboplatin. Gynecol. Oncol. 132, 455\u2013461 (2014).","journal-title":"Gynecol. Oncol."},{"key":"4314_CR42","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/carcin\/bgq249","volume":"32","author":"K Doberstein","year":"2011","unstructured":"Doberstein, K. et al. L1-CAM expression in ccRCC correlates with shorter patients survival times and confers chemoresistance in renal cell carcinoma cells. Carcinogenesis 32, 262\u2013270 (2011).","journal-title":"Carcinogenesis"},{"key":"4314_CR43","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/ijc.20869","volume":"115","author":"D Gast","year":"2005","unstructured":"Gast, D. et al. L1 augments cell migration and tumor growth but not beta 3 integrin expression in ovarian carcinomas. Int. J. Cancer. 115, 658\u2013665 (2005).","journal-title":"Int. J. Cancer."},{"key":"4314_CR44","doi-asserted-by":"publisher","unstructured":"Nakaoka, H. J. et al. Mint3-mediated L1CAM expression in fibroblasts promotes cancer cell proliferation via integrin alpha 5 beta 1 and tumour growth. Oncogenesis 6, https:\/\/doi.org\/10.1038\/oncsis.2017.27 (2017).","DOI":"10.1038\/oncsis.2017.27"},{"key":"4314_CR45","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","volume":"24","author":"R Perets","year":"2013","unstructured":"Perets, R. et al. Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models. Cancer Cell 24, 751\u2013765 (2013).","journal-title":"Cancer Cell"},{"key":"4314_CR46","doi-asserted-by":"publisher","unstructured":"Jia, D. Y., Nagaoka, Y., Katsumata, M. & Orsulic, S. Inflammation is a key contributor to ovarian cancer cell seeding. Sci Rep-Uk 8, https:\/\/doi.org\/10.1038\/s41598-018-30261-8 (2018).","DOI":"10.1038\/s41598-018-30261-8"},{"key":"4314_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01217-9","volume":"8","author":"J Ducie","year":"2017","unstructured":"Ducie, J. et al. Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma. Nat. Commun. 8, 990 (2017).","journal-title":"Nat. Commun."},{"key":"4314_CR48","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s43018-019-0006-x","volume":"1","author":"K Ganesh","year":"2020","unstructured":"Ganesh, K. et al. L1CAM defines the regenerative origin of metastasis-initiating cells in colorectal cancer. Nat. Cancer 1, 28\u201345 (2020).","journal-title":"Nat. Cancer"},{"key":"4314_CR49","doi-asserted-by":"publisher","first-page":"374","DOI":"10.4161\/cam.20832","volume":"6","author":"H Kiefel","year":"2012","unstructured":"Kiefel, H. et al. L1CAM: a major driver for tumor cell invasion and motility. Cell Adh Migr. 6, 374\u2013384 (2012).","journal-title":"Cell Adh Migr."},{"key":"4314_CR50","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1007\/s00018-010-0339-1","volume":"67","author":"MK Schafer","year":"2010","unstructured":"Schafer, M. K. & Altevogt, P. L1CAM malfunction in the nervous system and human carcinomas. Cell Mol. Life Sci. 67, 2425\u20132437 (2010).","journal-title":"Cell Mol. Life Sci."},{"key":"4314_CR51","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.cell.2014.01.040","volume":"156","author":"M Valiente","year":"2014","unstructured":"Valiente, M. et al. Serpins Promote Cancer Cell Survival and Vascular Co-Option in Brain Metastasis. Cell 156, 1002\u20131016 (2014).","journal-title":"Cell"},{"key":"4314_CR52","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.canlet.2014.08.020","volume":"354","author":"K Doberstein","year":"2014","unstructured":"Doberstein, K. et al. miR-21-3p is a positive regulator of L1CAM in several human carcinomas. Cancer Lett. 354, 455\u2013466 (2014).","journal-title":"Cancer Lett."},{"key":"4314_CR53","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S0140-6736(03)14342-5","volume":"362","author":"M Fogel","year":"2003","unstructured":"Fogel, M. et al. L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas. Lancet 362, 869\u2013875 (2003).","journal-title":"Lancet"},{"key":"4314_CR54","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1158\/0008-5472.CAN-09-3730","volume":"70","author":"S Wolterink","year":"2010","unstructured":"Wolterink, S. et al. Therapeutic Antibodies to Human L1CAM: Functional Characterization and Application in a Mouse Model for Ovarian Carcinoma. Cancer Res. 70, 2504\u20132515 (2010).","journal-title":"Cancer Res."},{"key":"4314_CR55","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1016\/S0002-9440(10)63058-1","volume":"159","author":"RC Casey","year":"2001","unstructured":"Casey, R. C. et al. Beta 1-integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids. Am. J. Pathol. 159, 2071\u20132080 (2001).","journal-title":"Am. J. Pathol."},{"key":"4314_CR56","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1023\/A:1026519016213","volume":"18","author":"RC Casey","year":"2000","unstructured":"Casey, R. C. & Skubitz, A. P. CD44 and beta1 integrins mediate ovarian carcinoma cell migration toward extracellular matrix proteins. Clin. Exp. Metastasis. 18, 67\u201375 (2000).","journal-title":"Clin. Exp. Metastasis."},{"key":"4314_CR57","doi-asserted-by":"publisher","unstructured":"Deng, B. Y. et al. Adrenomedullin expression in epithelial ovarian cancers and promotes HO8910 cell migration associated with upregulating integrin alpha 5 beta 1 and phosphorylating FAK and paxillin. J. Exp. Clin. Canc. Res. 31, https:\/\/doi.org\/10.1186\/1756-9966-31-19 (2012).","DOI":"10.1186\/1756-9966-31-19"},{"key":"4314_CR58","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1158\/0008-5472.CAN-07-5167","volume":"68","author":"K Sawada","year":"2008","unstructured":"Sawada, K. et al. Loss of E-cadherin promotes ovarian cancer metastasis via alpha(5)-integrin, which is a therapeutic target. Cancer Res. 68, 2329\u20132339 (2008).","journal-title":"Cancer Res."},{"key":"4314_CR59","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1038\/onc.2013.305","volume":"33","author":"E Serres","year":"2014","unstructured":"Serres, E. et al. Fibronectin expression in glioblastomas promotes cell cohesion, collective invasion of basement membrane in vitro and orthotopic tumor growth in mice. Oncogene 33, 3451\u20133462 (2014).","journal-title":"Oncogene"},{"key":"4314_CR60","doi-asserted-by":"publisher","unstructured":"Dean, M. et al. Loss of PTEN in Fallopian Tube Epithelium Results in Multicellular Tumor Spheroid Formation and Metastasis to the Ovary. Cancers (Basel) 11, https:\/\/doi.org\/10.3390\/cancers11060884 (2019).","DOI":"10.3390\/cancers11060884"},{"key":"4314_CR61","doi-asserted-by":"publisher","first-page":"e1008808","DOI":"10.1371\/journal.pgen.1008808","volume":"16","author":"O Kim","year":"2020","unstructured":"Kim, O. et al. In vivo modeling of metastatic human high-grade serous ovarian cancer in mice. PLoS Genet. 16, e1008808 (2020).","journal-title":"PLoS Genet."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-04314-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-04314-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-04314-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T17:04:17Z","timestamp":1671210257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-022-04314-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4314"],"URL":"https:\/\/doi.org\/10.1038\/s42003-022-04314-8","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,12]]},"assertion":[{"value":"22 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.D. serves as consultant\/scientific advisory board member of Repare Therapeutics, Mersana Therapeutics, and VOC Health. GBM receives support or acts as a consultant for: AstraZeneca, ImmunoMET, Ionis, Nanostring, PDX Pharmaceuticals, Signalchem Lifesciences, Symphogen, and Tarveda. No other authors report potential conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1362"}}